Atlas Trials

A Study of INCB050465 in Relapsed or Refractory Follicular Lymphoma

Clinical trial NCT03126019 · COMPLETED

Trial details

NCT number
NCT03126019
Sponsor
Incyte Corporation
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Lymphoma
Start date
2018-03-14
Primary completion
2021-02-26
Enrollment
126

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.